136 related articles for article (PubMed ID: 34209525)
1. Proof-of-Concept for the Analgesic Effect and Thermoregulatory Safety of Orally Administered Multi-Target Compound SZV 1287 in Mice: A Novel Drug Candidate for Neuropathic Pain.
Horváth ÁI; Szentes N; Tékus V; Payrits M; Szőke É; Oláh E; Garami A; Fliszár-Nyúl E; Poór M; Sár C; Kálai T; Pál S; Percze K; Scholz ÉN; Mészáros T; Tóth B; Mátyus P; Helyes Z
Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34209525
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors.
Horváth Á; Tékus V; Bencze N; Szentes N; Scheich B; Bölcskei K; Szőke É; Mócsai A; Tóth-Sarudy É; Mátyus P; Pintér E; Helyes Z
Pharmacol Res; 2018 May; 131():231-243. PubMed ID: 29438782
[TBL] [Abstract][Full Text] [Related]
3. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and Preclinical Investigation of
Forgács V; Németh E; Gyuricza B; Kis A; Szabó JP; Mikecz P; Mátyus P; Helyes Z; Horváth ÁI; Kálai T; Trencsényi G; Fekete A; Szikra D
ChemMedChem; 2020 Dec; 15(24):2470-2476. PubMed ID: 32935925
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
Tékus V; Horváth ÁI; Csekő K; Szabadfi K; Kovács-Valasek A; Dányádi B; Deres L; Halmosi R; Sághy É; Varga ZV; Adeghate E; Kőszegi T; Mátyus P; Gábriel R; Ferdinandy P; Pintér E; Helyes Z
Biomed Pharmacother; 2021 Feb; 134():111105. PubMed ID: 33338750
[TBL] [Abstract][Full Text] [Related]
6. Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.
Horváth Á; Menghis A; Botz B; Borbély É; Kemény Á; Tékus V; Csepregi JZ; Mócsai A; Juhász T; Zákány R; Bogdán D; Mátyus P; Keeble J; Pintér E; Helyes Z
Sci Rep; 2017 Jan; 7():39863. PubMed ID: 28067251
[TBL] [Abstract][Full Text] [Related]
7. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
[TBL] [Abstract][Full Text] [Related]
9. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve.
Labuz D; Spahn V; Celik MÖ; Machelska H
Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain.
Watabiki T; Kiso T; Tsukamoto M; Aoki T; Matsuoka N
Biol Pharm Bull; 2011; 34(7):1105-8. PubMed ID: 21720020
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action.
Nucci-Martins C; Martins DF; Nascimento LF; Venzke D; Oliveira AS; Frederico MJ; Silva FR; Brighente IM; Pizzolatti MG; Santos AR
J Ethnopharmacol; 2015 Dec; 175():273-86. PubMed ID: 26386380
[TBL] [Abstract][Full Text] [Related]
12. TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice.
Nguelefack TB; Dutra RC; Paszcuk AF; de Andrade EL; Calixto JB
BMC Complement Altern Med; 2015 Aug; 15():293. PubMed ID: 26303910
[TBL] [Abstract][Full Text] [Related]
13. A critical time window for the analgesic effect of central histamine in the partial sciatic ligation model of neuropathic pain.
Yu J; Tang YY; Wang RR; Lou GD; Hu TT; Hou WW; Yue JX; Ohtsu H; Shi LY; Zhang SH; Chen Z
J Neuroinflammation; 2016 Jun; 13(1):163. PubMed ID: 27342775
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice.
Bölcskei K; Helyes Z; Szabó Á; Sándor K; Elekes K; Németh J; Almási R; Pintér E; Pethő G; Szolcsányi J
Pain; 2005 Oct; 117(3):368-376. PubMed ID: 16150543
[TBL] [Abstract][Full Text] [Related]
15. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
16. Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice.
Sałat K; Cios A; Wyska E; Sałat R; Mogilski S; Filipek B; Więckowski K; Malawska B
Pharmacol Biochem Behav; 2014 Jul; 122():173-81. PubMed ID: 24726707
[TBL] [Abstract][Full Text] [Related]
17. Analgesic effect of dimethyl trisulfide in mice is mediated by TRPA1 and sst
Pozsgai G; Payrits M; Sághy É; Sebestyén-Bátai R; Steen E; Szőke É; Sándor Z; Solymár M; Garami A; Orvos P; Tálosi L; Helyes Z; Pintér E
Nitric Oxide; 2017 May; 65():10-21. PubMed ID: 28137611
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
19. Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms.
Hunyady Á; Hajna Z; Gubányi T; Scheich B; Kemény Á; Gaszner B; Borbély É; Helyes Z
Brain Res Bull; 2019 Apr; 147():165-173. PubMed ID: 30664920
[TBL] [Abstract][Full Text] [Related]
20. Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.
Marwaha L; Bansal Y; Singh R; Saroj P; Sodhi RK; Kuhad A
Inflammopharmacology; 2016 Dec; 24(6):319-334. PubMed ID: 27757590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
